Table 2.
Antimicrobial agents | No. of isolates (%) showing antibiotic resistance | ||
---|---|---|---|
| |||
P. aeruginosa (n=66) | A. baumannii (n=50) | S. maltophilia (n=6) | |
Piperacillin/tazobactam | 13 (19.7) | 46 (92) | NT |
Amikacin | 15 (22.7) | 42 (84) | NT |
Aztreonam | 17 (25.8) | 47 (94) | NT |
Levofloxacin | 10 (15.2) | 45 (90) | 1 (16.7) |
Gentamicin | 24 (36.4) | 43 (86) | NT |
Minocycline | 39 (59.1) | 45 (90) | 1 (16.7) |
Ceftriaxone | NT | 46 (92) | NT |
Ceftazidime | 15 (22.7) | 44 (88) | NT |
Cefotaxime | 56 (84.8) | 45 (90) | NT |
Cefepime | 19 (28.8) | 44 (88) | NT |
Imipenem | 8 (12.1) | 44 (88) | NT |
Meropenem | 12 (18.2) | 45 (90) | NT |
Trimethoprim/sulfamethoxazole | NT | 45 (90) | 1 (16.7) |
Colistin | 0 (0) | 0 (0) | 0 (0) |
NT: antibiotics not tested or not recommended by CLSI (Clinical and Laboratory Standards Institute).